9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (44%) |
| §103 only | 4 (44%) |
| Multi-statute (no §101) | 1 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAYMOND, LINNAE ELIZABETH | 1 | 50.0% | +58.9% |
| BORI, IBRAHIM D | 1 | 44.2% | +38.7% |
| NGUYEN, TRAN N | 1 | 61.9% | +16.9% |
| TRAN, JENNY NGAN | 1 | 37.5% | +46.7% |
| VOLKOV, ALEXANDER ALEXANDROVIC | 1 | 28.4% | +24.5% |
| YU, DELPHINUS DOU YI | 1 | 50.0% | +0.0% |
| HAYNES, DAWN TRINAH | 1 | 2.7% | +0.7% |
| LEE, DA WEI | 1 | 76.3% | +17.1% |
| NGO, MEAGAN N | 1 | 58.2% | +32.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18438563 | APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL | NGUYEN, TRAN N | 17d overdue |
| 18249016 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT | YU, DELPHINUS DOU YI | 23d |
| 18004585 | APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT | HAYNES, DAWN TRINAH | 28d |
| 18856351 | ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR | RAYMOND, LINNAE ELIZABETH | — |
| 18573608 | USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS | VOLKOV, ALEXANDER ALEXANDROVIC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18438563 | APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL | NGUYEN, TRAN N | 17d overdue |
| 18058956 | NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR | LEE, DA WEI | 4d overdue |
| 18056766 | RECTUM EXPANDING BALLOON CATHETER | NGO, MEAGAN N | 14d |
| 18856351 | ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR | RAYMOND, LINNAE ELIZABETH | — |
| 18695887 | PHARMACEUTICAL COMPOSITION COMPRISING CDK INHIBITOR AND ID2 ACTIVATOR FOR PREVENTION OR TREATMENT OF BLADDER CANCER | BORI, IBRAHIM D | — |
| 18681973 | TYMPANUM IMAGE PROCESSING APPARATUS AND METHOD FOR GENERATING NORMAL TYMPANUM IMAGE BY USING MACHINE LEARNING MODEL TO OTITIS MEDIA TYMPANUM IMAGE | TRAN, JENNY NGAN | — |
| 18573608 | USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS | VOLKOV, ALEXANDER ALEXANDROVIC | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| 3685 | 1 |
| 2615 | 1 |
| 1636 | 1 |
| 3686 | 1 |
| 2817 | 1 |
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856351 | ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR | RAYMOND, LINNAE ELIZABETH | — | §103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18695887 | PHARMACEUTICAL COMPOSITION COMPRISING CDK INHIBITOR AND ID2 ACTIVATOR FOR PREVENTION OR TREATMENT OF BLADDER CANCER | BORI, IBRAHIM D | 1629 | §103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18438563 | APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL | NGUYEN, TRAN N | 3685 | §101§103 | Final Rejection | 17d overdue | Pending | Feb 12, 2024 |
| 18681973 | TYMPANUM IMAGE PROCESSING APPARATUS AND METHOD FOR GENERATING NORMAL TYMPANUM IMAGE BY USING MACHINE LEARNING MODEL TO OTITIS MEDIA TYMPANUM IMAGE | TRAN, JENNY NGAN | 2615 | §103 | Final Rejection | — | Pending | Feb 07, 2024 |
| 18573608 | USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS | VOLKOV, ALEXANDER ALEXANDROVIC | — | §101§103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18249016 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT | YU, DELPHINUS DOU YI | 1636 | §101§112 | Non-Final OA | 23d | Pending | Apr 13, 2023 |
| 18004585 | APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT | HAYNES, DAWN TRINAH | 3686 | §101§103 | Final Rejection | 28d | Pending | Jan 06, 2023 |
| 18058956 | NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR | LEE, DA WEI | 2817 | §103 | Final Rejection | 4d overdue | Pending | Nov 28, 2022 |
| 18056766 | RECTUM EXPANDING BALLOON CATHETER | NGO, MEAGAN N | 3781 | §103 | Non-Final OA | 14d | Pending | Nov 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial